Goodwin Procter advised FibroGen, Inc. on the deal. FibroGen, Inc. announced its capped royalty monetization financing with NovaQuest Capital Management. The non-dilutive financing provides FibroGen with...
FibroGen’s Royalty Monetization Financing with NovaQuest Capital Management
Ritchie Bros’ $7.3 Billion Acquisition of IAA, Inc.
Goodwin Procter, McCarthy Tétrault and Skadden, Arps, Slate, Meagher & Flom advised Ritchie Bros. Incorporated, while Cooley and Blake, Cassels & Graydon advised IAA on the...
Hines and Apollo’s Majority Stake Acquisition in Aedes
Goodwin Procter advised Hines on the deal. Hines announced its joint venture with funds managed by Apollo Global Management, Inc. and Italian real estate company VI-BA S.r.l....
Novo Holdings’ Acquisition of KabaFusion
Goodwin Procter advised Novo Holdings on the deal. Novo Holdings announced its acquisition of KabaFusion from Pritzker Private Capital. Novo Holdings is a leading international healthcare...
NBD Ventures’ Launch of its T&T Opportunity Fund
Goodwin Procter advise NBD Ventures on the deal. NBD Ventures announced the launch of its T&T Opportunity Fund (NBD T&T Fund). The NBD T&T Fund will accelerate...
Eric Goupil, GIC, IK Partners, Keensight and Parquest’s Acquisition of Unither Pharmaceuticals
Kirkland advised GIC, while Latham & Watkins advised Ardian on the deal. Arsene, Goodwin and Deloitte Société d’Avocats advised IK Partners, GIC, Keensight Capital and Parquest....
Hospital for Special Surgery’s (HSS) $21 Million Series A Fundraising Round
Goodwin Procter advised Flare Capital on the deal. Flare Capital announced its investment in Hospital for Special Surgery’s (HSS) $21 million Series A fundraising round to launch...
Cruz Foam’s $18 Million Series A Funding Round
Goodwin Procter advised Cruz Foam on the deal. Cruz Foam announced its $18 million Series A funding round. The round was led by Helena, with participation by...
Landmark Bio’s Opening of State-of-the-art full-spectrum Development
Goodwin Procter advised Landmark Bio™ on the deal. Landmark Bio™ announced the opening of its state-of-the-art full-spectrum development and biomanufacturing facility in Watertown, Massachusetts. The 44,000 square-foot...
CharterUP’s $60 Million Series A Financing Round
Goodwin Procter advised CharterUP on the deal. CharterUP announced the completion of its $60 million in Series A. The financing round was led by Tritium Partners. CharterUP...
AbbVie’s Acquisition of DJS Antibodies
Goodwin Procter advised DJS Antibodies on the deal. AbbVie (NYSE: ABBV) announced the acquisition of DJS Antibodies Ltd (“DJS”), a privately-held UK-based biotechnology company dedicated to discovering...
Bregal Sagemount’s Formation of Bregal Sagemount Fund IV
Goodwin Procter and Carey Olsen advised Bregal Sagemount on the deal. Bregal Sagemount announced the formation of Bregal Sagemount Fund IV, which hit its hard cap...